IRAK4 and STAT6 degradation

搜索文档
Nurix Therapeutics (NasdaqGM:NRIX) Conference Transcript
2025-09-17 00:02
Nurix Therapeutics (NasdaqGM:NRIX) Conference September 16, 2025 11:00 AM ET Company ParticipantsArthur Sands - CEOOperatorAll right, good morning everyone. I'm Stephen Willey, one of the Senior Biotech Analysts here at Stifel, and glad to have with us, as part of the next session of day two for the I&I Summit, the CEO of Nurix Therapeutics, Arthur Sands. Arthur, thank you so much for your time today.Arthur SandsYeah, I'm happy to be here.OperatorWe're glad to have you. I know we spend a lot of our discussi ...